| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypertension, Vol 10, 425-436, Copyright © 1987 by American Heart Association
P Rudd, MG Price, LE Graham, BA Beilstein, SJ Tarbell, P Bacchetti and SP Fortmann
To confirm reports of increased absenteeism after worksite hypertension
screening, we performed a three-stage blood pressure screening among 5888
self-selected heterogeneous workers at 11 electronics plants using
standardized screening and labeling procedures. A total of 296 subjects
with mean systolic blood pressure of 140 mm Hg or greater or diastolic
blood pressure of 90 mm Hg or greater on all three occasions were
considered to have sustained hypertension. From the untreated normotensive
subjects matched for eight sociodemographic and occupational variables, we
prospectively selected one to three controls for each sustained
hypertensive subject. Uncorrected absenteeism rates for sustained
hypertensive subjects increased 22% from baseline in the postscreening
year. Correction by logarithmic transformation for skewed distributions and
by rates for matched controls for temporal trends reduced these changes to
statistical insignificance with high statistical power. Several subgroups
exhibited trends to increased absenteeism. At 12-month follow-up, the blood
pressure of the sustained hypertensive subjects showed mean decreases of
12.6/6.7 mm Hg (p less than 0.0001) after the majority had received
pharmacological antihypertensive treatment. These results suggest that
worksite hypertension screening and labeling produce insignificant
absenteeism change overall among self-selected heterogeneous work force
populations.
ARTICLES
Consequences of worksite hypertension screening. Changes in absenteeism
Department of Medicine, Stanford University Medical Center, California.
This article has been cited by other articles:
![]() |
D. Edelman, M. K. Olsen, T. K. Dudley, A. C. Harris, and E. Z. Oddone Impact of Diabetes Screening on Quality of Life Diabetes Care, June 1, 2002; 25(6): 1022 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rudd and S. P. Fortmann Some Cautions in Labeling Effects Arch Intern Med, November 1, 1991; 151(11): 2313 - 2313. [Abstract] [PDF] |
||||
![]() |
P. M. Fischer, K. H. Guinan, J. J. Burke II, W. B. Karp, and J. W. Richards Jr Impact of a Public Cholesterol Screening Program Arch Intern Med, December 1, 1990; 150(12): 2567 - 2572. [Abstract] [PDF] |
||||
![]() |
P. RUDD and S. P. FORTMANN Some Pitfalls in Disease Screening Arch Intern Med, May 1, 1990; 150(5): 1121 - 1124. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |